Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
ROC Curve | 7 | 2017 | 3579 | 0.830 |
Why?
|
Risk Assessment | 15 | 2024 | 23996 | 0.680 |
Why?
|
Models, Statistical | 7 | 2021 | 5079 | 0.600 |
Why?
|
Benchmarking | 1 | 2024 | 1045 | 0.580 |
Why?
|
Biometry | 2 | 2017 | 563 | 0.570 |
Why?
|
Cardiovascular Diseases | 17 | 2024 | 15501 | 0.570 |
Why?
|
Discriminant Analysis | 2 | 2011 | 223 | 0.470 |
Why?
|
Statistics, Nonparametric | 2 | 2017 | 2850 | 0.460 |
Why?
|
Data Interpretation, Statistical | 3 | 2013 | 2691 | 0.460 |
Why?
|
Area Under Curve | 4 | 2017 | 1638 | 0.440 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15266 | 0.430 |
Why?
|
New England | 2 | 2024 | 1054 | 0.380 |
Why?
|
Diet, Mediterranean | 3 | 2024 | 740 | 0.350 |
Why?
|
Electronic Health Records | 2 | 2024 | 4811 | 0.340 |
Why?
|
Coronary Disease | 6 | 2024 | 5914 | 0.330 |
Why?
|
Epidemiologic Research Design | 3 | 2011 | 368 | 0.330 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2024 | 3245 | 0.310 |
Why?
|
Cholesterol, HDL | 4 | 2021 | 1814 | 0.260 |
Why?
|
Computer Simulation | 7 | 2019 | 6241 | 0.250 |
Why?
|
Phobic Disorders | 3 | 2023 | 439 | 0.240 |
Why?
|
Lipoproteins | 2 | 2020 | 881 | 0.220 |
Why?
|
Postmenopause | 2 | 2024 | 2513 | 0.220 |
Why?
|
Models, Theoretical | 1 | 2015 | 3575 | 0.210 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2024 | 1390 | 0.210 |
Why?
|
C-Peptide | 1 | 2024 | 440 | 0.210 |
Why?
|
Survival Analysis | 1 | 2015 | 10090 | 0.200 |
Why?
|
Arteritis | 1 | 2024 | 158 | 0.200 |
Why?
|
Mental Disorders | 11 | 2023 | 6845 | 0.190 |
Why?
|
Hospitalization | 1 | 2021 | 10721 | 0.180 |
Why?
|
Insulin Resistance | 4 | 2024 | 3963 | 0.180 |
Why?
|
Lipoproteins, LDL | 2 | 2020 | 642 | 0.180 |
Why?
|
Triglycerides | 5 | 2021 | 2461 | 0.180 |
Why?
|
Risk Factors | 16 | 2024 | 74213 | 0.160 |
Why?
|
Amino Acids, Branched-Chain | 2 | 2020 | 269 | 0.160 |
Why?
|
Nomograms | 1 | 2021 | 230 | 0.160 |
Why?
|
Diabetes Mellitus, Type 2 | 5 | 2024 | 12148 | 0.160 |
Why?
|
Vitamin D | 2 | 2024 | 3303 | 0.150 |
Why?
|
Middle Aged | 30 | 2024 | 220920 | 0.150 |
Why?
|
Carbohydrates | 1 | 2020 | 390 | 0.150 |
Why?
|
Health Surveys | 8 | 2023 | 4061 | 0.150 |
Why?
|
Postprandial Period | 2 | 2020 | 315 | 0.150 |
Why?
|
Calibration | 3 | 2017 | 818 | 0.140 |
Why?
|
Aged | 18 | 2024 | 169310 | 0.140 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 9 | 2023 | 1988 | 0.140 |
Why?
|
Primary Prevention | 1 | 2024 | 1186 | 0.140 |
Why?
|
Lipoproteins, HDL | 2 | 2020 | 676 | 0.130 |
Why?
|
Fasting | 2 | 2020 | 1603 | 0.130 |
Why?
|
Female | 37 | 2024 | 392686 | 0.130 |
Why?
|
Humans | 48 | 2024 | 761572 | 0.120 |
Why?
|
Hormone Replacement Therapy | 1 | 2020 | 751 | 0.120 |
Why?
|
Cholecalciferol | 1 | 2019 | 553 | 0.120 |
Why?
|
Decision Support Techniques | 1 | 2024 | 1998 | 0.110 |
Why?
|
Metabolomics | 2 | 2020 | 1659 | 0.110 |
Why?
|
Lipids | 2 | 2024 | 3341 | 0.110 |
Why?
|
Cholesterol, LDL | 4 | 2024 | 2382 | 0.100 |
Why?
|
Male | 27 | 2024 | 360842 | 0.100 |
Why?
|
Cohort Studies | 4 | 2024 | 41493 | 0.100 |
Why?
|
Hypertriglyceridemia | 1 | 2015 | 293 | 0.100 |
Why?
|
Proportional Hazards Models | 4 | 2024 | 12463 | 0.100 |
Why?
|
Logistic Models | 4 | 2017 | 13255 | 0.100 |
Why?
|
Suicide | 1 | 2023 | 1601 | 0.100 |
Why?
|
Comorbidity | 11 | 2023 | 10508 | 0.100 |
Why?
|
Sample Size | 1 | 2015 | 841 | 0.100 |
Why?
|
Dietary Supplements | 2 | 2024 | 3415 | 0.090 |
Why?
|
Glycosylation | 2 | 2024 | 1097 | 0.090 |
Why?
|
Blood Glucose | 1 | 2024 | 6391 | 0.090 |
Why?
|
Insulin | 1 | 2024 | 6597 | 0.090 |
Why?
|
Depressive Disorder, Major | 3 | 2023 | 4761 | 0.080 |
Why?
|
Computational Biology | 1 | 2021 | 3517 | 0.080 |
Why?
|
Age of Onset | 4 | 2023 | 3306 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2024 | 3763 | 0.080 |
Why?
|
Exercise | 2 | 2022 | 5890 | 0.080 |
Why?
|
Incidence | 6 | 2024 | 21355 | 0.080 |
Why?
|
Lipoprotein(a) | 2 | 2024 | 480 | 0.070 |
Why?
|
Prognosis | 3 | 2024 | 29629 | 0.070 |
Why?
|
United States | 14 | 2024 | 72335 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8002 | 0.070 |
Why?
|
Linear Models | 1 | 2017 | 5872 | 0.070 |
Why?
|
Multivariate Analysis | 2 | 2019 | 12059 | 0.070 |
Why?
|
Polysaccharides | 2 | 2024 | 1014 | 0.070 |
Why?
|
Placebos | 2 | 2020 | 1667 | 0.070 |
Why?
|
Self Psychology | 1 | 2005 | 8 | 0.060 |
Why?
|
Proteins | 1 | 2020 | 6032 | 0.060 |
Why?
|
Adult | 18 | 2024 | 221203 | 0.060 |
Why?
|
Inflammation | 2 | 2021 | 10773 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15843 | 0.060 |
Why?
|
Mental Health Services | 2 | 2006 | 1730 | 0.060 |
Why?
|
Population Surveillance | 2 | 2005 | 2598 | 0.060 |
Why?
|
Switzerland | 1 | 2024 | 324 | 0.060 |
Why?
|
Interview, Psychological | 2 | 2004 | 809 | 0.060 |
Why?
|
Algorithms | 2 | 2021 | 14032 | 0.050 |
Why?
|
Prevalence | 9 | 2023 | 15732 | 0.050 |
Why?
|
Double-Blind Method | 3 | 2024 | 12341 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2017 | 20099 | 0.050 |
Why?
|
Specialization | 1 | 2006 | 778 | 0.050 |
Why?
|
Immunoglobulin G | 2 | 2024 | 4544 | 0.050 |
Why?
|
World Health Organization | 2 | 2005 | 1322 | 0.050 |
Why?
|
Age Factors | 6 | 2021 | 18398 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2020 | 6403 | 0.040 |
Why?
|
Apolipoprotein B-100 | 1 | 2020 | 157 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2006 | 3708 | 0.040 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2020 | 155 | 0.040 |
Why?
|
Horses | 1 | 2020 | 300 | 0.040 |
Why?
|
Lipoproteins, VLDL | 1 | 2020 | 201 | 0.040 |
Why?
|
Osteoporotic Fractures | 1 | 2024 | 411 | 0.040 |
Why?
|
Apolipoproteins B | 1 | 2021 | 386 | 0.040 |
Why?
|
Apolipoprotein A-I | 1 | 2020 | 299 | 0.040 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2020 | 276 | 0.040 |
Why?
|
Biological Specimen Banks | 1 | 2024 | 783 | 0.040 |
Why?
|
Health Services Research | 1 | 2006 | 1812 | 0.040 |
Why?
|
Case-Control Studies | 3 | 2024 | 22176 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 5 | 2006 | 6019 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2015 | 14607 | 0.040 |
Why?
|
Apolipoproteins | 1 | 2020 | 326 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17904 | 0.040 |
Why?
|
Databases, Protein | 1 | 2020 | 387 | 0.040 |
Why?
|
Body Mass Index | 3 | 2020 | 12954 | 0.040 |
Why?
|
Medicine | 1 | 2006 | 942 | 0.040 |
Why?
|
Molecular Weight | 1 | 2020 | 2186 | 0.040 |
Why?
|
Sex Factors | 3 | 2019 | 10553 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2020 | 1126 | 0.030 |
Why?
|
Aftercare | 1 | 2023 | 914 | 0.030 |
Why?
|
Dyslipidemias | 1 | 2024 | 868 | 0.030 |
Why?
|
Time Factors | 3 | 2024 | 39970 | 0.030 |
Why?
|
Prospective Studies | 4 | 2024 | 54426 | 0.030 |
Why?
|
Anxiety Disorders | 2 | 2002 | 2720 | 0.030 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26127 | 0.030 |
Why?
|
Adolescent | 11 | 2023 | 88324 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2024 | 3769 | 0.030 |
Why?
|
Patient Compliance | 1 | 2024 | 2690 | 0.030 |
Why?
|
Regression Analysis | 2 | 2019 | 6344 | 0.030 |
Why?
|
Metabolome | 1 | 2020 | 989 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1520 | 0.030 |
Why?
|
Homeostasis | 1 | 2024 | 3323 | 0.030 |
Why?
|
Cause of Death | 1 | 2024 | 3683 | 0.030 |
Why?
|
Smoking | 2 | 2021 | 9053 | 0.030 |
Why?
|
Ligands | 1 | 2020 | 3272 | 0.030 |
Why?
|
Socioeconomic Factors | 3 | 2019 | 7827 | 0.030 |
Why?
|
Mortality | 1 | 2024 | 2901 | 0.030 |
Why?
|
Psychotic Disorders | 2 | 2005 | 3223 | 0.030 |
Why?
|
Sampling Studies | 2 | 2004 | 615 | 0.030 |
Why?
|
Fractures, Bone | 1 | 2024 | 2046 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2548 | 0.020 |
Why?
|
Women's Health | 1 | 2020 | 2065 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2020 | 1809 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1879 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3443 | 0.020 |
Why?
|
Residence Characteristics | 1 | 2019 | 2094 | 0.020 |
Why?
|
Mass Screening | 1 | 2005 | 5428 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4124 | 0.020 |
Why?
|
Alleles | 1 | 2020 | 6864 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3826 | 0.020 |
Why?
|
Chronic Disease | 1 | 2003 | 9319 | 0.020 |
Why?
|
Public Health | 1 | 2002 | 2669 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2006 | 5336 | 0.020 |
Why?
|
Risk | 1 | 2020 | 9610 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 64684 | 0.020 |
Why?
|
Mood Disorders | 2 | 2005 | 1127 | 0.020 |
Why?
|
Calcium | 1 | 2019 | 5722 | 0.020 |
Why?
|
Software | 1 | 2020 | 4434 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2006 | 303 | 0.020 |
Why?
|
Unemployment | 1 | 2006 | 210 | 0.010 |
Why?
|
Family Practice | 1 | 2006 | 512 | 0.010 |
Why?
|
Psychiatry | 2 | 2006 | 1693 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10212 | 0.010 |
Why?
|
Hallucinations | 1 | 2005 | 366 | 0.010 |
Why?
|
Diet | 1 | 2020 | 8075 | 0.010 |
Why?
|
Complementary Therapies | 1 | 2006 | 486 | 0.010 |
Why?
|
Absenteeism | 1 | 2003 | 247 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16592 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2017 | 39107 | 0.010 |
Why?
|
Self-Assessment | 1 | 2003 | 397 | 0.010 |
Why?
|
Hypertension | 1 | 2021 | 8540 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12690 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2020 | 15936 | 0.010 |
Why?
|
Cross-Cultural Comparison | 1 | 2004 | 635 | 0.010 |
Why?
|
Marital Status | 1 | 2002 | 426 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2880 | 0.010 |
Why?
|
Substance-Related Disorders | 2 | 2006 | 4420 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2006 | 2426 | 0.010 |
Why?
|
Education | 1 | 2002 | 537 | 0.010 |
Why?
|
Obesity | 1 | 2021 | 12947 | 0.010 |
Why?
|
Interviews as Topic | 1 | 2005 | 2696 | 0.010 |
Why?
|
Reference Values | 1 | 2005 | 4920 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2004 | 2358 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2004 | 2707 | 0.010 |
Why?
|
Young Adult | 1 | 2023 | 59255 | 0.010 |
Why?
|
Psychometrics | 1 | 2005 | 3065 | 0.010 |
Why?
|
Income | 1 | 2002 | 1877 | 0.010 |
Why?
|
Neoplasms | 1 | 2019 | 22173 | 0.010 |
Why?
|
Primary Health Care | 1 | 2005 | 4686 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 2006 | 5440 | 0.000 |
Why?
|
Animals | 1 | 2020 | 168467 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2005 | 58986 | 0.000 |
Why?
|
Child | 1 | 2005 | 80156 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2002 | 80646 | 0.000 |
Why?
|
Concepts
(196)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(43)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_